N-cyano sulfoximines: COX inhibition, anticancer activity, cellular toxicity, and mutagenicity. - Wikidata - awgldk - TriplyDB

N-cyano sulfoximines: COX inhibition, anticancer activity, cellular toxicity, and mutagenicity.

N-cyano sulfoximines: COX inhibition, anticancer activity, cellular toxicity, and mutagenicity.

http://www.wikidata.org/entity/Q39229336

about

Enantioselective imidation of sulfides via enzyme-catalyzed intermolecular nitrogen-atom transfer Pentafluorosulfanyl-containing flufenamic acid analogs: Syntheses, properties and biological activities Sulfoximines: a neglected opportunity in medicinal chemistry.Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical Modification.Synthesis of a Sulfonimidamide-Based Analog of Tasisulam and Its Biological Evaluation in the Melanoma Cell Lines SKMel23 and A375.Palladium/Copper-Cocatalyzed Oxidative Amidobrominations of Alkenes.Copper-Catalyzed Direct Sulfoximination of Heteroaromatic N-Oxides by Dual C-H/N-H Dehydrogenative Cross-Coupling.Access to N-cyanosulfoximines by transition metal-free iminations of sulfoxides.Copper-catalyzed N-thioetherification of sulfoximines using disulfides.Transition metal-free aroylation of NH-sulfoximines with methyl arenes.Sulfur Imidations by Light-Induced Ruthenium-Catalyzed Nitrene Transfer Reactions Synthesis of N-cyano-substituted sulfilimine and sulfoximine derivatives of S0859 and their biological evaluation as sodium bicarbonate co-transport inhibitors The Synthesis of Chiral Benzothiazine and Thiazinoquinoline Derivatives Light-Induced Ruthenium-Catalyzed Nitrene Transfer Reactions: A Photochemical Approach towards N-Acyl Sulfimides and Sulfoximines N-Alkylations ofNH-Sulfoximines andNH-Sulfondiimines with Alkyl Halides Mediated by Potassium Hydroxide in Dimethyl Sulfoxide Enantioselective Nitrene Transfer to Sulfides Catalyzed by a Chiral Iron Complex Copper-Catalyzed Oxidative Cross-Coupling of Sulfoximines and Alkynes Sulfoxide-to-Sulfilimine Conversions: Use of Modified Burgess-Type Reagents The Copper-Catalyzed OxidativeN-Acylation of Sulfoximines

P2860

Q34133881-BEC57663-7B44-45D4-AC9D-0D3EB2C22724 Q36142192-6D457FA3-97EE-47A3-8BDF-F21562651C14 Q38128269-460DBF1F-26A1-4361-A656-FA33E9C1F761 Q38602644-F2F8E6CC-574F-45CE-A095-8F66EF38492E Q38724420-2BE46634-FADE-47DD-874F-E601C07F5724 Q46705899-A5F39D06-BEA3-4C57-A27A-4ED4FCFD86C6 Q48136672-D9A1AE80-8D95-47F7-A647-4CB043979B72 Q48364779-45B378BD-AAA4-4BF8-95F8-5E0A588C95DE Q51144004-92CF1948-BB8C-44A4-ADA4-4D15608CD01F Q51797526-7B7CE3F3-BB8D-426D-9E6B-18C91C308F1B Q57404748-58B38B73-43EF-453D-A73D-D205CBE82A60 Q57404749-43642BED-1E83-4A7E-9AD4-D9D40279829C Q57404750-9B0C68D0-BF11-4B84-93D5-F607F2F18455 Q57404759-707031A5-B275-441A-9BA2-5C519E204487 Q57404768-1E6C2AD2-23D6-42B8-B15C-74B866518909 Q57404776-0330ED82-949F-43C4-BF22-6C466338F7EF Q57404778-A263C939-1BCB-438E-ABA5-042166F5C990 Q57404785-DC42B151-1406-4D47-84FA-B02989B051DF Q57404787-F7E9765D-00E1-4525-AD43-E863871E33EC

P2860

N-cyano sulfoximines: COX inhibition, anticancer activity, cellular toxicity, and mutagenicity.

http://www.wikidata.org/entity/Q39229336

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

N-cyano sulfoximines: COX inhi ...... ar toxicity, and mutagenicity.

@en

N-cyano sulfoximines: COX inhi ...... ar toxicity, and mutagenicity.

@nl

type

label

N-cyano sulfoximines: COX inhi ...... ar toxicity, and mutagenicity.

@en

N-cyano sulfoximines: COX inhi ...... ar toxicity, and mutagenicity.

@nl

prefLabel

N-cyano sulfoximines: COX inhi ...... ar toxicity, and mutagenicity.

@en

N-cyano sulfoximines: COX inhi ...... ar toxicity, and mutagenicity.

@nl

P1433

Q39229336-F8F34CDE-FD8D-410C-8A4F-56B1FDB94F1A

P1476

Q39229336-EFBC4B58-3E8C-4570-97D8-FDAA45AB091A

P2093

Q39229336-15263A76-9534-4949-8213-6AC7EDB1FB00

Q39229336-41B18420-3DE0-473F-8B42-49BFA92C69E5

Q39229336-6148F02C-47F7-4329-B02D-137231A7955F

Q39229336-6C84EBB7-B3F1-4CB1-8564-9F705241D1A4

Q39229336-85374DDE-50DE-4629-B06F-50A3F02C568A

Q39229336-A0B02EFB-2AB5-40AC-954F-D1307A8D7892

Q39229336-A9E38E17-6365-4581-9CFF-E151E365DA7A

Q39229336-F6CFE8EE-EAB1-4FF0-AAAE-951072D57B66

P2860

Q39229336-0C269E34-F1A0-41A6-9905-054F3F8BD2EF

Q39229336-132D4BCC-E852-40CE-9C47-827F297B6365

Q39229336-1E9A1D4A-8ECE-40C1-B04A-54AC09A7B596

Q39229336-45E05EE8-5601-4A95-B79D-E202EE2C2C6A

Q39229336-54A5CD0B-6E2B-45D5-819A-777C090D3996

Q39229336-584F2CAB-0BDA-4080-9729-3731A82455BE

Q39229336-62AB0582-8D3D-4144-865F-C542839199A2

Q39229336-68B23946-2EFD-46E6-A471-A00D54708099

Q39229336-70998C8F-DE44-4CDD-961E-6229A9AC4FA3

Q39229336-75EE4510-0A2E-4562-A183-384D58880B95

P304

Q39229336-7B5E82BF-4518-4851-A844-AE31666AFDE1

P31

Q39229336-703674D9-31C9-4BFD-83CB-B687FEEF736E

P356

Q39229336-86CFBB7E-F0B8-4B79-84C6-87503FD70C81

P433

Q39229336-49C493AE-7459-4B61-9BD7-82BF1222D791

P478

Q39229336-7D841DAB-5E43-41CF-AB79-D75848C41BE4

P50

Q39229336-28CBF590-CB1D-4C03-BF20-E603C5DD058C

Q39229336-2B08C440-C092-43B6-BE5C-E1434A3B9140

Q39229336-5B5F8742-6300-43A5-B3AE-3ECB67051A20

P577

Q39229336-BB1073BA-514A-4DFA-9A5D-8C75A9CDD3FA

P698

Q39229336-8F0ED88C-1CBE-46AF-87E7-3317869323A4

P356

P1433

P1476

N-cyano sulfoximines: COX inhi ...... ar toxicity, and mutagenicity.

@en

P2093

Hannah Baars

http://www.w3.org/2001/XMLSchema#string

Helmut Buschmann

http://www.w3.org/2001/XMLSchema#string

Jens Malte Baron

http://www.w3.org/2001/XMLSchema#string

Katharina Czaja

http://www.w3.org/2001/XMLSchema#string

Kerstin Bluhm

http://www.w3.org/2001/XMLSchema#string

Philipp M Amann

http://www.w3.org/2001/XMLSchema#string

Regine Redelstein

http://www.w3.org/2001/XMLSchema#string

Stefanie Mersmann

http://www.w3.org/2001/XMLSchema#string

P2860

Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

Inflammation and cancer: chemical approaches to mechanisms, imaging, and treatment.

Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy.

2,3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors.

BAY 1000394, a novel cyclin-dependent kinase inhibitor, with potent antitumor activity in mono- and in combination treatment upon oral application.

Buthionine sulfoximine promotes methylglyoxal-induced apoptotic cell death and oxidative stress in endothelial cells.

Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.

Novel nicotinic action of the sulfoximine insecticide sulfoxaflor.

P304

217-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201200403

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23225780

http://www.w3.org/2001/XMLSchema#string